ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY

N/A

Manufactured by Bath and Body Works, Distr.

42 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY

ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bath and Body Works, Distr.. The most commonly reported adverse reactions for ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY include APPLICATION SITE RASH, HYPERSENSITIVITY, PAIN OF SKIN, SEIZURE, ALOPECIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY.

Top Adverse Reactions

APPLICATION SITE RASH2 reports
HYPERSENSITIVITY2 reports
PAIN OF SKIN2 reports
SEIZURE2 reports
ALOPECIA1 reports
APPLICATION SITE BURN1 reports
APPLICATION SITE PAIN1 reports
BACK PAIN1 reports
BLISTER1 reports
BREAST CANCER1 reports
CHEMICAL BURN1 reports
CHEMICAL BURN OF SKIN1 reports
CHILLS1 reports
COUGH1 reports
DEATH1 reports
ERYTHEMA1 reports
GAIT DISTURBANCE1 reports
GASTRIC CANCER1 reports
IMPAIRED WORK ABILITY1 reports
MACULE1 reports
MOBILITY DECREASED1 reports
MUSCULOSKELETAL CHEST PAIN1 reports
MYALGIA1 reports
PLASMA CELL MYELOMA1 reports
PRODUCT CONTAMINATION CHEMICAL1 reports
PURULENT DISCHARGE1 reports
RASH PUSTULAR1 reports
RECALLED PRODUCT1 reports
RESPIRATION ABNORMAL1 reports
RETCHING1 reports
SCAB1 reports
SKIN EXFOLIATION1 reports
SKIN INFECTION1 reports
SKIN IRRITATION1 reports
SKIN LACERATION1 reports
SKIN WARM1 reports
SLEEP DISORDER1 reports
THERAPY CESSATION1 reports

Report Outcomes

Out of 12 classified reports for ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY:

Serious 100.0%Non-Serious 0.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male9 (100.0%)

Reports by Age

Age 141 reports
Age 331 reports
Age 391 reports
Age 491 reports
Age 501 reports
Age 541 reports
Age 851 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY?

This profile reflects 42 FDA FAERS reports that mention ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY?

Frequently reported terms in FAERS include APPLICATION SITE RASH, HYPERSENSITIVITY, PAIN OF SKIN, SEIZURE, ALOPECIA, APPLICATION SITE BURN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY?

Labeling and FAERS entries often list Bath and Body Works, Distr. in connection with ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.